On October 29, MaxLinear fell 5.35% in Regular Trading, trading at $70.135 per share, with turnover of $54.2184 million.
The main catalyst cited by recent market reports was that at least two brokers lowered their target prices after the company had already reported third-quarter results and fourth-quarter revenue guidance above expectations, dampening near-term risk appetite.
Earlier disclosures showed third-quarter adjusted EPS of $0.62, above market expectations of $0.56, while revenue rose 72% year over year to $218.1 million. The company also guided fourth-quarter revenue to $240 million-$260 million, ahead of the $226.6 million consensus. Even so, the positive earnings and guidance were not enough to fully offset valuation pressure following the target-price reductions, helping explain the stock's latest weakness.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments